Web: | mayocliniclabs.com |
---|---|
Email: | mcl@mayo.edu |
Telephone: | 800-533-1710 |
International: | +1 855-379-3115 |
Values are valid only on day of printing. |
Determination of cross-reactive immunologic material status using leukocytes from patients with Pompe disease
Evaluating the best strategy for enzyme replacement therapy for patients with Pompe disease
This test is used to determine cross-reactive immunological material (CRIM) status in patients with Pompe disease.
CRIM status is important when assessing whether immunosuppression is needed when initiating enzyme replacement therapy for patients with Pompe disease.
See Newborn Screen Follow-up for Pompe Disease In Special Instructions
Western Blot